The clinical phenotype and evolution of antisynthetase syndrome (ASS) are heterogeneous.
This study was therefore undertaken to identify subgroups of ASS patients with similar …

The question of whether primary lateral sclerosis (PLS) is a nosological entity distinct from
amyotrophic lateral sclerosis (ALS) has been the subject of controversy since it was first …

The antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ) are used in long-term
treatment of connective tissue diseases and dermatological disorders and are generally …

We describe a long-term observational study of a large cohort of patients with sporadic
inclusion body myositis and propose a sporadic inclusion body myositis weakness composite …

Necrotizing autoimmune myopathy (NAM) is a group of acquired myopathies characterized
by prominent myofiber necrosis with little or no muscle inflammation. Recently, researchers …

Objective To report the clinicopathologic features and outcome of myositis in patients treated
with immune checkpoint inhibitors (ICIs) (irMyositis). Methods We retrospectively analyzed …

A clinical and electrophysiological study was performed in 119 Type 1A Charcot-Marie-Tooth
disease (CMT1A) patients with proven 17p11.2 duplication. Onset of the first functional …

Hypokalaemic periodic paralysis (hypoPP) is an autosomal dominant muscle disorder
characterized by episodic attacks of muscle weakness associated with a decrease in blood …

Early management of respiratory muscle failure using mechanical ventilation and high-dose
abatacept with CD86 receptor occupancy monitoring combined with ruxolitinib may be …

<p id="p005">We describe a kindred with slowly progressive gastrointestinal symptoms and
autonomic neuropathy caused by autosomal dominant, hereditary systemic amyloidosis. …